Skip to content
10-Q

Quarterly Report

HARMONY BIOSCIENCES HOLDINGS, INC. HRMY

0001558370-25-006394

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 57.42M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $158.18M
Long Term Debt Q1 2025 · Dec 31, 2024 $163.02M
Short Term Debt Q1 2025 · Mar 31, 2025 $17.5M
Short Term Debt Q1 2025 · Dec 31, 2024 $16.25M
Short Term Investments Q1 2025 · Mar 31, 2025 $17.96M
Short Term Investments Q1 2025 · Dec 31, 2024 $14.19M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $489M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $453M
Current Liabilities Q1 2025 · Mar 31, 2025 $175.12M
Current Liabilities Q1 2025 · Dec 31, 2024 $175.08M
Total Liabilities Q1 2025 · Mar 31, 2025 $335.01M
Total Liabilities Q1 2025 · Dec 31, 2024 $340.05M
Current Assets Q1 2025 · Mar 31, 2025 $642.69M
Current Assets Q1 2025 · Dec 31, 2024 $579.25M
Total Assets Q1 2025 · Mar 31, 2025 $1.06B
Total Assets Q1 2025 · Dec 31, 2024 $999.2M
Shares Diluted Q1 2025 · Mar 31, 2024 57.6M sh
Capex Q1 2025 · Mar 31, 2024 $5K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $31.14M
Stockholders Equity Q1 2025 · Mar 31, 2024 $515.39M
Stockholders Equity Q1 2025 · Dec 31, 2023 $466.99M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.67
Eps Basic Q1 2025 · Mar 31, 2024 $0.68
Sga Expense Q1 2025 · Mar 31, 2024 $25.68M
Rd Expense Q1 2025 · Mar 31, 2024 $22.19M
Net Income Q1 2025 · Mar 31, 2024 $38.33M
Operating Income Q1 2025 · Mar 31, 2024 $52.03M
Gross Profit Q1 2025 · Mar 31, 2024 $127.13M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $27.48M
Revenue Q1 2025 · Mar 31, 2024 $154.62M